Table 2.
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
Variables | HR (95% CI) | p Value | HR (95% CI) | p Value |
Age < 65 years | 1.56 (1.27–1.91) | <0.001 | 2.01 (1.61–2.51) | <0.001 |
Female sex | 1.40 (1.16–1.70) | <0.001 | 1.30 (1.08–1.58) | 0.007 |
Charlson comorbidities | ||||
AIDS | 0.00 (0.00–a) | 0.968 | ||
Cancer | 1.30 (0.97–1.76) | 0.081 | 1.24 (0.92–1.68) | 0.160 |
Cerebrovascular disease | 1.46 (1.17–1.81) | 0.001 | 1.35 (1.06–1.72) | 0.015 |
Congestive heart failure | 0.96 (0.71–1.31) | 0.810 | ||
Dementia | 2.94 (2.07–4.19) | <0.001 | 3.11 (2.12–4.57) | <0.001 |
Diabetes with end-organ damage | 0.99 (0.66–1.48) | 0.955 | ||
Diabetes without end-organ damage | 0.90 (0.72–1.14) | 0.383 | ||
Metastatic cancer | 1.77 (0.79–3.97) | 0.165 | ||
Myocardial infarction | 1.25 (0.75–2.10) | 0.393 | ||
Peptic ulcer disease | 1.57 (1.29–1.89) | <0.001 | 1.48 (1.22–1.80) | <0.001 |
Peripheral vascular disease | 1.73 (1.12–2.66) | 0.013 | 1.53 (0.99–2.36) | 0.057 |
Hemiplegia or paraplegia | 0.92 (0.48–1.79) | 0.815 | ||
Kidney disease | 1.40 (1.06–1.85) | 0.018 | 1.25 (0.94–1.66) | 0.129 |
Connective tissue disease | 1.47 (1.03–2.10) | 0.034 | 1.27 (0.88–1.81) | 0.199 |
Severe liver disease | 0.86 (0.21–3.44) | 0.829 |
HR: hazard ratio; CI: confidence interval; AIDS: acquired immunodeficiency syndrome; COPD: chronic obstructive pulmonary disease.
aDo not converge.